China Tightens Grip on Offshore IPOs, Targeting Tech and Biotech

Beijing is imposing stricter rules on Chinese companies that use offshore entities to list on foreign stock exchanges. This move creates significant new hurdles for U.S. dollar funds investing in China's tech and biotech sectors. The change focuses on companies using a Variable Interest Entity (VIE) structure. This common method allows foreign investment in sensitive industries while technically keeping the firm under Chinese control. Regulators will now scrutinize these offshore vehicles more closely. According to industry sources, the goal is to ensure no asset sales escape government oversight. This reflects broader caution in supervising strategically important sectors. For any offshore structure that gains approval, listing applicants must now make a specific new commitment to Chinese regulators. They must promise to use the listing proceeds to develop their core business within China's borders. This policy shift signals a more controlled environment for companies seeking foreign capital and could slow the pipeline for initial public offerings abroad.